+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sulbactam"

Multidrug Resistant Bacteria Global Market Report 2024 - Product Thumbnail Image

Multidrug Resistant Bacteria Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Acinetobacter infections - Pipeline Insight, 2024 - Product Thumbnail Image

Acinetobacter infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2024 - Product Thumbnail Image

Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Complicated Intra-Abdominal Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Complicated Intra-Abdominal Infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Carbapenem-Resistant Enterobacteriaceae - Pipeline Insight, 2024 - Product Thumbnail Image

Carbapenem-Resistant Enterobacteriaceae - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 70 Pages
  • Global
From
Bacteraemia - Pipeline Insight, 2024 - Product Thumbnail Image

Bacteraemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
From
From
From
  • 16 Results (Page 1 of 1)
Loading Indicator

Sulbactam is an antibiotic drug used in combination with other antibiotics to treat a variety of bacterial infections. It is a beta-lactamase inhibitor, meaning it blocks the action of enzymes that can break down other antibiotics, allowing them to remain active and effective against bacteria. Sulbactam is commonly used in combination with ampicillin to treat infections caused by susceptible bacteria, such as urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. It is also used to treat some types of meningitis and endocarditis. Sulbactam is a key component of many antibiotics used to treat infectious diseases, and is an important part of the global effort to combat antibiotic resistance. It is used in combination with other antibiotics to increase the effectiveness of treatment and reduce the risk of antibiotic resistance. Some companies in the Sulbactam market include Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline plc, Sanofi, and AstraZeneca plc. Show Less Read more